Top compounds associated with response to MOCS3


Feature Type Standardized
Nominal ANOVA
mRNA indisulam CTRPv2 pan-cancer AAC -0.13 7e-05
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA Gemcitabine gCSI pan-cancer AAC -0.19 0.0008
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.12 0.001
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC -0.1 0.002
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.002
mRNA BRD6340 CTRPv2 pan-cancer AAC -0.11 0.002
Download CSV